Kim Bullock, MD

Psychiatrist

Clinical Associate Professor, Psychiatry and Behavioral Sciences

Comprehensive Epilepsy Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Outpatient Psychiatry Clinic

  • 401 Quarry Road
  • Stanford, CA 94304
  • Phone: 650-498-9111
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: George Washington University Medical School (1994) DC

Residency: Stanford University School of Medicine (2002) CA

Subspecialty, United Council for Neurologic Subspecialties, Behavioral Neurology & Neuropsychiatry (2012)

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2006)

Internship: Washington Hospital Center (1995) DC

Residency, Stanford University, Psychiatry (2002)

Internship, Washington Hospital Center, Internal Medicine (1995)

MD, George Washington University, Medicine (1994)

BA, University of California, Animal Physiology (1989)

BA, University of California, Psychology (1989)

Honors & Awards

Special Thanks and Recognition Award, Palo Alto Veterans Administration (July 1998)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Ethics Commentary: Ethical Considerations in Caring for People Living With Addictions
Laura Weiss Roberts. (2011). Ethics Commentary: Ethical Considerations in Caring for People Living With Addictions. Focus, 9.

Group therapy for patients with psychogenic nonepileptic seizures: A pilot study
Barry, J. J., Wittenberg, D., Bullock, K. D., Michaels, J. B., Classen, C. C., & Fisher, R. S. (2008). Group therapy for patients with psychogenic nonepileptic seizures: A pilot study. EPILEPSY & BEHAVIOR, 13(4), 624-629.

Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder
Koran, L. M., Aboujaoude, E., Bullock, K. D., Franz, B., Gamel, N., & Elliott, M. (2005). Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. JOURNAL OF CLINICAL PSYCHIATRY, 66(3), 353-359.

Doubl-blind, 0nce-weekly Oral Morphine in Treatment Resistant Obsessive-Compulsive Disorder
Koran, L., Elias Aboujaoude, Kim Bullock, & Nona Gamel. (2005). Doubl-blind, 0nce-weekly Oral Morphine in Treatment Resistant Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry.

Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices
Barry, J. J., Lembke, A., & Bullock, K. D. (2004). Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices. CLINICAL EEG AND NEUROSCIENCE, 35(1), 4-13.

Group psychotherpy for patients with non-epileptic seizures: a pilot study (abstract).
Wittenberg D, Michaels J, Ford C, Bullock K, & Barry JJ. (2004). Group psychotherpy for patients with non-epileptic seizures: a pilot study (abstract). Epilepsia, 45(Suppl. 7).

Citalopram for compulsive shopping disorder: An open-label study followed by double-blind discontinuation
Koran, L. M., Chuong, H. W., Bullock, K. D., & Smith, S. C. (2003). Citalopram for compulsive shopping disorder: An open-label study followed by double-blind discontinuation. JOURNAL OF CLINICAL PSYCHIATRY, 64(7), 793-798.

Psychopharmacology of compulsive buying
Bullock KD, & Koran LM. (2003). Psychopharmacology of compulsive buying. Drugs of Today, 39(9).

Citalopram treatment of compulsive shopping: An open-label study
Koran, L. M., Bullock, K. D., Hartston, H. J., Elliott, M. A., & D'Andrea, V. (2002). Citalopram treatment of compulsive shopping: An open-label study. JOURNAL OF CLINICAL PSYCHIATRY, 63(8), 704-708.

REDUCED MORTALITY RISK IN ALCOHOLICS WHO ACHIEVE LONG-TERM ABSTINENCE
Bullock, K. D., Reed, R. J., & Grant, I. (1992). REDUCED MORTALITY RISK IN ALCOHOLICS WHO ACHIEVE LONG-TERM ABSTINENCE. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 267(5), 668-672.